Thrombotic Microangiopathy Clinical Trials

19 clinical trials for Thrombotic Microangiopathy across international registries, including 2 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Investigation of short- and long-term therapy outcome in treatment of thrombotic microangiopathies – retrospective anonymized data collection. — RECRUITING
• Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients — RECRUITING
• A Study Using Real-world Data to Examine Outcomes in Children and Adults Who Develop a Blood Clotting Disorder Called Thrombotic Microangiopathy (TMA) After Undergoing a Hematopoietic Stem Cell Transplant (HSCT). — COMPLETED
• Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant — COMPLETED · PHASE3
• Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy — NOT_YET_RECRUITING · NA
• Study of Ravulizumab in Pediatric Participants With HSCT-TMA — COMPLETED · PHASE3
• N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy — ACTIVE_NOT_RECRUITING · PHASE2
• Determinants of quality of care in patients with Thrombotic Thrombocytopenic Purpura (TTP) in Germany and the influence of rapid diagnostic facilities — OTHER
• Prospective evaluation of ADAMTS-13, von Willebrand factor and Interleukin-6 in vascular surgery — OTHER
• Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger — TERMINATED · PHASE3
• French National Cohort MATRIX "Renal and Systemic Thrombotic Microangiopathy" — OTHER
• Influence of Metabolic Profiles on Drug Safety in Routine Care — OTHER
• Incidence of Snakebite Associated Thrombotic Microangiopathy & Role of Peripheral Blood Smear as a Predictor of Clinical Outcome — OTHER
• PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RAVULIZUMAB IN ADULT PARTICIPANTS WHO HAVE THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH A TRIGGER — COMPLETED · PHASE3
• Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants — COMPLETED
• Cross-sectional Evaluation of clinical symptoms and epidemiologic parameters in patients with TMA, differentiated by laboratory param-eters (CESAR) — OTHER
• OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy — OTHER
• International Registry and Biorepository for TMA(Thrombotic Microangiopathy) — TERMINATED
• Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy — TERMINATED · PHASE2

Refine this search